| 常用名 | Tafolecimab | CAS号 | 2225109-03-3 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia[1]. 物理化学性质: CAS号:2225109-03-3 常用中文名:Tafolecimab 常用英文名:Tafolecimab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |